Literature DB >> 12112509

Magnetic resonance safety testing of a newly-developed fiber-optic cardiac pacing lead.

Wilson Greatbatch1, Victor Miller, Frank G Shellock.   

Abstract

PURPOSE: To assess magnetic resonance (MR) safety for a newly developed, fiber-optic cardiac pacing lead.
MATERIALS AND METHODS: MR safety was assessed for the fiber-optic cardiac pacing lead by evaluating magnetic field interactions and heating. Translational attraction and torque were evaluated using a 1.5-Tesla MR system and previously described, standardized techniques. MR imaging-related heating was assessed using a 1.5-Tesla MR system and a transmit/receive, body radiofrequency (RF) coil with the fiber-optic lead positioned to simulate an in vivo condition in a saline-filled phantom. The phantom had dimensions similar to a human subject's torso and head. A fluoroptic thermometry system was used to record temperatures on and near the electrodes of the fiber-optic pacing lead at five-second intervals immediately before and during 20 minutes of MR imaging performed at a whole-body-averaged specific absorption rate (SAR) of 1.5 W/kg. Temperatures were also recorded from a reference site during this experiment.
RESULTS: Magnetic field interactions for the fiber-optic lead were minimal (deflection angle, 23 degrees; torque, +2). The highest temperature change recorded for the fiber-optic cardiac pacing lead and reference site was +0.8 degrees C.
CONCLUSION: The minor magnetic field interactions and relative lack of heating for the fiber-optic pacing lead indicate that it should be safe for patients with this device to undergo MR imaging procedures using MR systems operating at 1.5-T or less and at a whole-body-averaged SARs up to 1.5 W/kg. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12112509     DOI: 10.1002/jmri.10129

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  5 in total

1.  Magnetic resonance imaging, pacemakers and implantable cardioverter-defibrillators: current situation and clinical perspective.

Authors:  M J W Götte; I K Rüssel; G J de Roest; T Germans; R F Veldkamp; P Knaapen; C P Allaart; A C van Rossum
Journal:  Neth Heart J       Date:  2010-01       Impact factor: 2.380

2.  Safety of cardiovascular magnetic resonance in patients with cardiovascular implants and devices.

Authors:  S K Prasad; D J Pennell
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

3.  Orthodontic springs and auxiliary appliances: assessment of magnetic field interactions associated with 1.5 T and 3 T magnetic resonance systems.

Authors:  J Kemper; A N Priest; D Schulze; B Kahl-Nieke; G Adam; A Klocke
Journal:  Eur Radiol       Date:  2006-06-29       Impact factor: 5.315

Review 4.  Deep brain stimulation and electromagnetic interference.

Authors:  Shervin Rahimpour; Musa Kiyani; Sarah E Hodges; Dennis A Turner
Journal:  Clin Neurol Neurosurg       Date:  2021-02-25       Impact factor: 1.876

Review 5.  Magnetic resonance imaging in patients with cardiac pacemakers: era of "MR Conditional" designs.

Authors:  Jerold S Shinbane; Patrick M Colletti; Frank G Shellock
Journal:  J Cardiovasc Magn Reson       Date:  2011-10-27       Impact factor: 5.364

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.